Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Prenyl-protein transferase inhibitors reported by Merck & Co.

Jan. 3, 1997

U.S. IND granted for Scotia's photodynamic drug

Jan. 2, 1997

Novel antiangiogenic compounds from ADIR

Jan. 2, 1997

Geron/P&U collaboration on telomerase inhibitors

Dec. 31, 1996

FDA identifies issues to be addressed for AccuSite approval

Dec. 31, 1996

U.K. launch for aromatase inhibitor

Dec. 31, 1996

Natural antitumor/antifungal agent disclosed by Fujisawa

Dec. 31, 1996

Dolastatin 10 derivatives from Teikoku Hormone

Dec. 31, 1996

Andrx licenses chemoprotective agent to Asta

Dec. 30, 1996

Natural antineoplastic agents described by Fujisawa

Dec. 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.